4:00 pm Dynavax Technologies to receive $5.4 mln milestone from AstraZeneca (AZN); AstraZeneca to assume responsibility for future clinical development of investigational TLR-9 agonist for treatment of asth
View todays social media effects on DVAX
View the latest stocks trending across Twitter. Click to view dashboard
See who Dynavax is hiring next, click here to view
